Strategic Analysis of the U.S. Next Generation Sequencing Markets

NEW YORK, Sept. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Analysis of the U.S. Next Generation Sequencing Markets

http://www.reportlinker.com/p0453494/Strategic-Analysis-of-the-US-Next-Generation-Sequencing-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

This research service provides a strategic analysis of the next generation sequencing market. This study provides a detailed overview of the next generation sequencing instruments on the market, an analysis of competitors, market drivers, market restraints, and a market outlook. Furthermore, this study presents statistics on the National Institutes of Health (NIH) American Recovery and Reinvestment Act (ARRA) instrumentation grants awarded for next generation sequencing instruments. Lastly, a market outlook is provided describing market mergers, acquisitions, partnerships, expectations for third-generation sequencing instruments, and takeaways from 2010 market activities.

Table of Contents

Executive Summary Slides 6-8

Product Analysis Slides 9-21

National Institutes of Health American Recovery and Reinvestment Act Funding Analysis Slides 22-29

Market Drivers and Restraints Slides 30-35

Market Outlook Slides 36-45

About Frost & Sullivan Slides 46-50

List of Figures

Next Generation Sequencing Market: NIH ARRA Instrumentation Grants Statistics (U.S.), 2009-2010 24

Next Generation Sequencing Market: NIH ARRA Instrumentation Grant Statistics for DNA Sequencing Technology (U.S.), 2009-2010 25

Next Generation Sequencing Market: NIH ARRA Instrumentation Grant Statistics for Illumina (U.S.), 2009-2010 26

Next Generation Sequencing Market: NIH ARRA Instrumentation Grant Statistics for Roche 454 (U.S.), 2009-2010 27

Next Generation Sequencing Market: NIH ARRA Instrumentation Grant Statistics for Life Technologies (U.S.), 2009-2010 28

Next Generation Sequencing Market: NIH ARRA Instrumentation Grant Statistics for Qiagen (U.S.), 2009-2010 29

Next Generation Sequencing Market: Market Drivers (U.S.), 2011-2013 31-33

Next Generation Sequencing Market: Market Restraints (U.S.), 2011-2013 34-35

To order this report:

Genomics Industry: Strategic Analysis of the U.S. Next Generation Sequencing Markets

Genomics Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.